|

A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania

RECRUITINGSponsored by Memorial Sloan Kettering Cancer Center
Actively Recruiting
SponsorMemorial Sloan Kettering Cancer Center
Started2023-04-13
Est. completion2026-04
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

The purpose of this study is to learn more about the challenges with breast cancer diagnosis in Tanzania and the support available to improve this process.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Participant Inclusion Criteria for interviews and focus group discussions (Aims 1 and 2):

* Breast cancer survivor, patient advocate or key healthcare personnel

  * Key healthcare personnel are defined as hospital and laboratory leaders, pathologists, laboratory scientists and technicians, oncologists, nurses, and surgeons, with:
  * \>12 months of employment at the affiliated institution
  * Administrative or clinical involvement in the delivery of breast cancer care services.
* Age 18 years and above
* Permanent residents or citizens of Tanzania
* Participant and/or LAR willing and able to consent
* Fluent in Swahili and/or English by self-report

Participant Exclusion Criteria:

* Key stakeholder not residing at their particular institutions during data collection will be excluded.

Eligibility criteria for Chart Reviews (Aim 1)

Inclusion Criteria for chart review:

* Age 18 years and above
* Permanent residents or citizens of Tanzania
* Received breast cancer diagnosis

Exclusion Criteria for chart review:

* Participants less than 18 years of age

Conditions2

Breast CancerCancer

Locations1 site

Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, 10065
Diana Ng, MD212-639-7209NgD2@mskcc.org

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.